Literature DB >> 6875686

Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected.

J C Sisson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6875686

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  6 in total

1.  Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinic's experience of treating 2,512 consecutive patients during 1940 through 2000.

Authors:  Ian D Hay; William M McConahey; John R Goellner
Journal:  Trans Am Clin Climatol Assoc       Date:  2002

2.  Use of radioactive iodine for thyroid cancer.

Authors:  Megan R Haymart; Mousumi Banerjee; Andrew K Stewart; Ronald J Koenig; John D Birkmeyer; Jennifer J Griggs
Journal:  JAMA       Date:  2011-08-17       Impact factor: 56.272

Review 3.  Radionuclide therapy of the thyroid.

Authors:  S E Clarke
Journal:  Eur J Nucl Med       Date:  1991

4.  Guidelines Are Not Gospel!

Authors:  Gilbert H Daniels; Peter A Kopp
Journal:  Thyroid       Date:  2019-06       Impact factor: 6.568

Review 5.  The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: natural history, diagnosis, differential diagnosis and management.

Authors:  C A Koch; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 5.467

6.  Radioiodine remnant ablation in stage I adult papillary thyroid carcinoma: does it improve postoperative outcome?

Authors:  Ian D Hay; Suneetha Kaggal; Geoffrey B Thompson
Journal:  Eur Thyroid J       Date:  2022-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.